We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
E-therapeutics Plc | LSE:ETX | London | Ordinary Share | GB00B2823H99 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.00 | 9.00 | 9.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 475k | -8.27M | -0.0142 | -6.34 | 52.55M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/4/2020 17:16 | Above average volume today. | matt123d | |
01/4/2020 16:49 | wow these sort of deals being done even in this environment Sitryx are a fellow tenant of Oxford Science Park Sitryx signs potential $880m drug development deal | the stigologist | |
01/4/2020 15:53 | Limited freefloat Little support on way down from 40p to 10p so should be little resistance on the way up Seriously undervalued compared to Private 'unicorn' peers like Exscientia, BenevolentAI , Google Deepmind etc News 'imminent' : "we are in late stage discussions regarding a number of exciting potential collaborations" | the stigologist | |
01/4/2020 14:38 | Nice mopping up going on I think | ishwar | |
01/4/2020 12:15 | Yes, going a lot higher here. | matt123d | |
01/4/2020 07:51 | $1bn Exscientia copying ETX | the stigologist | |
31/3/2020 18:25 | I meant significant game changing news. Like AZN or GSK type news | the stigologist | |
30/3/2020 22:02 | Obviously the 200k and 150k trades cleared the supply that had been sitting there and the smaller trades hit the RSP to move the price. | matt123d | |
30/3/2020 17:50 | Yes, I couldn't get my head around that one either . Actually more sells than buys reported not that the volume would suggest imminent news or even more that it had leaked. Volumes would be multiples of today.. Nonetheless , quite encouraged / pleased with the rise. | assagai | |
30/3/2020 17:38 | Why does it look like news imminent? | dplewis1 | |
30/3/2020 15:36 | Looks like news imminent? | the stigologist | |
30/3/2020 10:20 | Price firming up now after a few days consolidation. | matt123d | |
24/3/2020 15:36 | Senior Tech guy Jonny Wray interview with ProActive Investors | the stigologist | |
23/3/2020 22:43 | Lovely read that | harvey26311 | |
23/3/2020 19:45 | Fabulous release today and illustrates the power of their technology. | jpuff | |
23/3/2020 19:28 | New Closing 52 Week High Perfect set-up for continuation | the stigologist | |
23/3/2020 15:53 | Can't see how this won't get good overnight press in Newspaper market reports Definitely one to consider scaling into 8p is a crucial resistance/support zone so todays intraday test looks v.positive going forward | the stigologist | |
23/3/2020 10:17 | Good job Stig... re..Yes, but pointing it out is a little crass :)...... ...well....maybe.... | thefartingcommie | |
23/3/2020 10:15 | Ha ha But genuinely not even logged in to trading account this morning This could be gamechanging for ETX and more importantly Covid19 Why worry about pennies when this could go 100p+ and help fight Covid19 | the stigologist | |
23/3/2020 10:09 | Yes, but pointing it out is a little crass :) | dplewis1 | |
23/3/2020 10:09 | Seriously guys I've been calling this brilliantly so far i think a technical breakout to test highs of 40p could occur in this market Imagine if Governments Big Pharma and Billionaires like Musk and Gates say ok we give you time of day or a few million for R&D or access to your databases? | the stigologist | |
23/3/2020 10:06 | My post 231 on Sunday was prophetic | the stigologist | |
23/3/2020 10:04 | Game Changing Elon Musk level genius | the stigologist | |
23/3/2020 08:53 | 12-16p is the next range to target short term. | matt123d |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions